• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma

byKathleen Lau
January 28, 2021
in StudyGraphics
0
Share on FacebookShare on Twitter

RELATED REPORTS

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

Tags: asctastctautologous stem cell transplantautologous stem cell transplantationbloodblood cancerbortezomibcancercomplete responsehematologyinductioninfectionlenalidomideleukopeniamaintenancemaintenance therapymultiple myelomamyelomanear complete responseneutropenianewly diagnosednewly diagnosed multiple myelomano significant differenceoncologyoverall survivalpfspost-asctprogression-free survivalstandard of carestem cellstem cell transplantsurvivalsurvival outcomestandem asct
Previous Post

#VisualAbstract: Prognosis for advanced melanoma has improved between 2013 to 2017 for patients in the Netherlands

Next Post

Machine learning-based PRAISE score may aid in the prediction of adverse events following an acute coronary syndrome

RelatedReports

Incidental findings common with breast imaging, often benign
Chronic Disease

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

August 21, 2025
Improved survival with bufulfan-cyclophosphamide combination vs total body irradiation
Pharma

Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths

August 20, 2025
Radiation plus hormone therapy may improve prostate cancer survival
Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025
#VisualAbstract: Inavolisib Increased Overall Survival in PIK3CA-Mutated Advanced Breast Cancer
StudyGraphics

#VisualAbstract: Inavolisib Increased Overall Survival in PIK3CA-Mutated Advanced Breast Cancer

August 8, 2025
Next Post
Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis

Machine learning-based PRAISE score may aid in the prediction of adverse events following an acute coronary syndrome

Tamsulosin therapy associated with significant reduction of symptoms of overactive bladder

Insurance status linked to transfer decisions in trauma cases

Laryngeal mask airway may not be superior for neonate resuscitation

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women
  • GSK and Hengrui Pharma Forge $500 Million China Collaboration
  • #VisualAbstract: Ciprofloxacin is Noninferior to Aminoglycoside–Ciprofloxacin for Treatment of Bubonic Plague
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.